Scientists say new drugs are on the way for patients with ALS. The latest is a two-drug combo that appears to slow the progression of the fatal nerve disease with a modest but meaningful benefit.
Multiple studies now confirm earlier research: Dexamethasone and hydrocortisone, drugs that reduce an immune system's overreaction, can help reduce deaths of hospitalized COVID-19 patients.
New studies strongly support the use of corticosteroids to treat COVID-19. These drugs are inexpensive and widely available. Early controversy over their effectiveness may now largely be settled.
A vaccine against the coronavirus needs to keep people from getting very sick and dying. But preventing the spread of the disease is also important, and vaccines delivered by nasal spray may do that.
Emily Miller was central in defending the FDA commissioner, Dr. Stephen Hahn, after he falsely said that blood plasma could lower the death rate from COVID-19 by more than a third.
New vaccines usually take years to get the approval of the Food and Drug Administration. But the Trump administration suggests the FDA may greenlight a coronavirus vaccine by the end of the year.
A frontline doctor and advocate for Georgia's immigrant and refugee populations on supporting and encouraging some of the people most vulnerable to COVID-19.
Young athletes — especially girls — can struggle with a breathing problem that appears to be asthma. The real cause of the problem is in the vocal cords.
An uninsured Colorado man who had appendicitis owed $80,232 after two surgeries. After months of negotiating with the hospital, he still owes far more than most insurers would pay for the procedures.
The Food and Drug Administration's chief said Sunday the therapy reduces deaths among COVID-19 patients by 35%. On Monday he apologized, acknowledging that statistic greatly exaggerates any benefit.
New vaccines usually take years to get the approval of the Food and Drug Administration. But the Trump administration suggests the FDA may greenlight a coronavirus vaccine by the end of the year.
NPR's Ari Shapiro talks with Dr. Eric Topol of the Scripps Research Translational Institute about his concerns about the use of convalescent plasma for COVID-19 treatment.
Mail-order prescriptions are another victim of recent changes to post office operations around the country. For some people, getting your mail on time could be a matter of life or death.
NPR's Ari Shapiro talks with Health and Human Services Secretary Alex Azar about the Food and Drug Administration allowing the use of convalescent plasma to treat COVID-19.
NPR takes a look at the effectiveness of convalescent plasma in treating COVID-19 and discusses a patient in Hong Kong who got infected with the coronavirus twice.
